Medifast, Inc.MEDNYSE
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | -9.51% |
| Q3 2025 | -14.76% |
| Q2 2025 | -9.12% |
| Q1 2025 | -2.29% |
| Q4 2024 | -15.50% |
| Q3 2024 | -21.13% |
| Q2 2024 | 10.02% |
| Q1 2024 | -10.05% |
| Q4 2023 | -12.63% |
| Q3 2023 | -11.71% |
| Q2 2023 | -10.82% |
| Q1 2023 | -4.04% |
| Q4 2022 | -14.36% |
| Q3 2022 | -13.94% |
| Q2 2022 | 10.32% |
| Q1 2022 | 6.80% |
| Q4 2021 | -8.11% |
| Q3 2021 | 8.44% |
| Q2 2021 | 18.66% |
| Q1 2021 | 21.38% |
| Q4 2020 | 1.12% |
| Q3 2020 | 21.55% |
| Q2 2020 | 17.45% |
| Q1 2020 | 2.15% |
| Q4 2019 | -10.85% |
| Q3 2019 | 8.22% |
| Q2 2019 | 12.87% |
| Q1 2019 | 12.48% |
| Q4 2018 | -0.50% |
| Q3 2018 | 25.17% |
| Q2 2018 | 19.23% |
| Q1 2018 | 21.12% |
| Q4 2017 | 3.51% |
| Q3 2017 | 3.57% |
| Q2 2017 | 4.56% |
| Q1 2017 | 9.43% |
| Q4 2016 | -6.35% |
| Q3 2016 | -10.35% |
| Q2 2016 | 2.72% |
| Q1 2016 | 18.25% |